tirzepatide surpass New research from the SURPASS-EARLY trial found that improved glycemic control, body weight, and waist circumference over 104 weeks compared with intensified conventional care in adults with early type 2 diabetes SURPASS-CVOT Published: Large Trial Confirms

Patients with existing chronic kidney disease face higher risk of acute kidney injury if dehydration develops

Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the diabetes control and complications trial/epidemiology of diabetes interventions and complications cohort

Targeting the progression of chronic kidney disease

Oral tirzepatide is not appropriate for individuals with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

Thankfully, the board of pharmacy in Iowa mandated that SmartScripts, located near Iowa City, to be monitored and provide periodic detailed reports

It is also unsafe to try refreezing tirzepatide after it has thawed